Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these days has made its stock even more attractive. But when a dividend yield ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

Pfizer's 5.7% dividend yield, while attractive, raises significant sustainability concerns. The company's payout ratio has skyrocketed to 436%, far exceeding the 75% threshold that typically ...

A much better financial metric to consider when evaluating the sustainability of the dividend is free cash flow.Pfizer generated free cash flow of around $9.8 billion in 2024.

Pfizer's 5.7% dividend yield, while attractive, raises significant sustainability concerns. The company's payout ratio has skyrocketed to 436%, far exceeding the 75% threshold that typically ...

Its dividend appears to be sustainable despite the uncertainties. 10 stocks we like better than Pfizer › Income investors have liked Pfizer (NYSE: PFE) for years.

Income investors have liked Pfizer (NYSE: PFE) for years. Wondering if Pfizer's 7.6% dividend yield is sustainable? Pfizer's management remains confident about the company's ability to fund the ...

Instead, the more pragmatic approach is to examine its financials to determine how sustainable the dividend is. Pfizer's dividend payout ratio of 122.5% looks concerning at first glance.

Its dividend appears to be sustainable despite the uncertainties. Pfizer can cover its dividends with free cash flow, but doesn't have a huge cushion.

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer's 7.6% dividend yield is sustainable?